Loading...
Docoh

Redhill Biopharma (RDHL)

News

From Benzinga Pro
Stocks That Hit 52-Week Lows On Wednesday
11 May 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Wednesday, 807 companies reached new 52-week lows.
12 Health Care Stocks Moving In Monday's Intraday Session
9 May 22
Intraday Update, Markets, Movers
RedHill Biopharma Announces $15M Registered Direct Offering With A Leading Healthcare Investor
9 May 22
News, Offerings
RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has entered into a definitive agreement with a single leading
Stocks That Hit 52-Week Lows On Friday
6 May 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Friday, 1043 companies hit new 52-week lows.
Stocks That Hit 52-Week Lows On Wednesday
4 May 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
During Wednesday's trading, 435 companies set new 52-week lows.
26 Stocks Moving in Thursday's Pre-Market Session
21 Apr 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Redbox Entertainment Inc. (NASDAQ: RDBX) rose 31.9% to $3.35 in pre-market trading after jumping around 25% on Wednesday.
RedHill Biopharma Says Opaganib Can Potentially Work Against COVID-19 Omicron Subvariants
11 Apr 22
Biotech, News, Penny Stocks, Health Care, Movers, Trading Ideas, General
RedHill Biopharma Announce Study Results Showing Opaganib Was Observed To Have In Vitro Efficacy Against Omicron SARS-CoV-2 Variant
11 Apr 22
Biotech, General
Oral opaganib's reported potent in vitro activity against Omicron adds to previously observed inhibition of Delta and other SARS-CoV-2 variants of concern that cause COVID-19; Testing conducted by The University of
64 Biggest Movers From Yesterday
18 Mar 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Kidpik Corp. (NASDAQ: PIK) shares surged 158.2% to settle at $4.75 on Thursday after the company announced a partnership with The Walt Disney Co.
Redhill Biopharma: Q4 Earnings Insights
17 Mar 22
Earnings, News
Redhill Biopharma (NASDAQ:RDHL) reported its Q4 earnings results on Thursday, March 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Redhill Biopharma Q4 Sales $22.10M Miss $24.08M Estimate
17 Mar 22
Earnings, News
Redhill Biopharma (NASDAQ:RDHL) reported quarterly sales of $22.10 million which missed the analyst consensus estimate of $24.08 million by 8.22 percent. This is a 2.98 percent increase over sales of $21.46 million the
Earnings Scheduled For March 17, 2022
17 Mar 22
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • TransGlobe Energy (NASDAQ:TGA) is estimated to report earnings for its fourth quarter.
Redhill Biopharma's Earnings: A Preview
16 Mar 22
Earnings
Redhill Biopharma (NASDAQ:RDHL) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement. Analysts estimate that Redhill Biopharma will report an earnings per share (EPS) of $-0.33.
RedHill, Kukbo Ink Oral Opaganib Licensing Pact For COVID-19 In South Korea
15 Mar 22
Biotech, News, Penny Stocks, Health Care, Contracts, Movers, Trading Ideas, General
Stocks That Hit 52-Week Lows On Tuesday
15 Mar 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
During Tuesday's session, 454 stocks hit new 52-week lows.
RedHill Biopharma Reports License Deal With Kukbo For Oral Opaganib For COVID-19 In South Korea; Co. To Receive Upfront Payment Of $1.5M, Eligible For Up To $5.6M In Milestone Payments
15 Mar 22
Biotech, News, FDA, General
RedHill to receive $1.5 million upfront and is eligible for up to $5.6 million in milestone payments in addition to royalties on net sales from Kukbo Opaganib's Phase 2/3 clinical data shows improved viral RNA
Stocks That Hit 52-Week Lows On Tuesday
8 Mar 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
Tuesday's session saw 729 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Monday
7 Mar 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Monday, 524 stocks hit new 52-week lows.
Stocks That Hit 52-Week Lows On Friday
4 Mar 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Friday, 368 stocks hit new 52-week lows.
RedHill Biopharma's Upamostat Shows 100% Efficacy In Non-Hospitalized COVID-19 Patients
1 Mar 22
Biotech, News, Penny Stocks, Health Care, General
RedHill Biopharma Ltd (NASDAQ: RDHL) has

Press releases

From Benzinga Pro
RedHill Presents New Talicia® Data Analyses at DDW 2022
25 May 22
Press Releases
Talicia's efficacy and safety profile evaluated in patients with H. pylori infection and diabetes mellitus, a large and challenging patient population associated with sub-optimal outcomes with clarithromycin-based H.
RedHill Biopharma Announces $15 Million Registered Direct Offering with a Leading Healthcare Investor
9 May 22
Offerings, Press Releases
TEL AVIV, Israel and RALEIGH, N.C, May 9, 2022 /PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has entered
RedHill Reports Potent Inhibition of Omicron with Oral COVID-19 Drug Candidate Opaganib In Vitro
11 Apr 22
Press Releases
- Oral opaganib's reported potent in vitro activity against Omicron adds to previously observed inhibition of Delta and other SARS-CoV-2 variants of concern that cause COVID-19; Testing conducted by The University of
RedHill Biopharma Ltd Announces Potent Omicron Inhibition with RedHill's Opaganib
11 Apr 22
News, Press Releases
Oral opaganib's reported potent in vitro activity against Omicron adds to previously observed inhibition of Delta and other SARS-CoV-2 variants of concern that cause COVID-19; Testing conducted by The University of Hong
Biopharma Stocks Targeting Crohn's Disease In $13.7 Billion Market (STAB, ARNA, GILD and RDHL)
16 Mar 22
News, Press Releases
Biopharmaceutical stocks are targeting Crohn’s Disease in developing drugs in 2022. Research finds that this is a $13.7 billion market ripe for sector stock catalysts such as profit and dividends. CATALYSTS
RedHill Biopharma to Host Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights Webcast on March 17, 2022
10 Mar 22
Press Releases
TEL AVIV, Israel and RALEIGH, NC, March 10, 2022 /PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it will
RedHill Announces Positive Phase 2 Study Results with Oral RHB-107 in Non-Hospitalized COVID-19
1 Mar 22
Press Releases
TEL AVIV, Israel and RALEIGH, N.C., March 1, 2022 /PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced